CAS No.: 52214-84-3 — Ciprofibrate (环丙贝特)

1. Primary Information

English name:	Ciprofibrate
CAS No.:	52214-84-3
Molecular formula:	C₁₃H₁₄Cl₂O₃
Molecular weight:	289.15 g/mol
SMILES:	CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
Structural class:
Other identifiers:	ciprofibrate Hyperlipen Lipanor Modalim Oroxadin

2. Suppliers & Pricing

Supplier	Pack size	Purity	Price (CNY)	Storage conditions	Lead time	Notes
Kehua Intelligence	20mg	HPLC≥98%	480	2-8℃	in stock	-
Kehua Intelligence	1g	>98%	24	2-8℃	in stock	-
Kehua Intelligence	5g	>98%	68	2-8℃	in stock	-
Kehua Intelligence	25g	>98%	222	2-8℃	in stock	-
Kehua Intelligence	100g	>98%	732	2-8℃	in stock	-
Kehua Intelligence	500g	>98%	2640	2-8℃	in stock	-

3. Structures

3.1 2D structure

3.2 3D structure

-1 -2 -3 32 33 0 1 0 0 0 0 0999 V2000 5.8071 0.7018 -0.5690 Cl 0 0 0 0 0 0 0 0 0 0 0 0 3.4158 2.0529 0.4780 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -2.1854 -0.5979 -0.5779 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.1525 1.0239 0.6112 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.7970 -0.6768 -0.8378 O 0 0 0 0 0 0 0 0 0 0 0 0 3.4371 -0.7173 -0.1379 C 0 0 1 0 0 0 0 0 0 0 0 0 4.2234 0.5153 0.1865 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0615 -0.5651 1.2151 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9520 -0.6858 -0.2541 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1713 -1.5106 0.5558 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3422 0.1685 -1.1728 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2190 -1.4811 0.4470 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0481 0.1980 -1.2816 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8222 -0.6269 -0.4712 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8716 0.3336 0.2590 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3924 1.7362 -0.1031 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5714 -0.0255 1.7112 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3507 0.1570 -0.0587 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9221 -1.4408 -0.7916 H 0 0 0 0 0 0 0 0 0 0 0 0 3.4339 -0.3647 2.0765 H 0 0 0 0 0 0 0 0 0 0 0 0 4.9113 -1.1975 1.4481 H 0 0 0 0 0 0 0 0 0 0 0 0 1.6320 -2.1897 1.2683 H 0 0 0 0 0 0 0 0 0 0 0 0 1.9356 0.7987 -1.8299 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.8122 -2.1479 1.0658 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.5072 0.8471 -2.0215 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.0110 2.4967 0.3881 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.3639 1.9349 0.2143 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.4621 1.9171 -1.1818 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.7615 -1.0865 1.9092 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.2164 0.5450 2.3901 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.5428 0.2027 2.0076 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.0991 0.8916 0.3907 H 0 0 0 0 0 0 0 0 0 0 0 0 1 7 1 0 0 0 0 2 7 1 0 0 0 0 3 14 1 0 0 0 0 3 15 1 0 0 0 0 4 18 1 0 0 0 0 4 32 1 0 0 0 0 5 18 2 0 0 0 0 6 7 1 0 0 0 0 6 8 1 0 0 0 0 6 9 1 0 0 0 0 6 19 1 0 0 0 0 7 8 1 0 0 0 0 8 20 1 0 0 0 0 8 21 1 0 0 0 0 9 10 2 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 10 22 1 0 0 0 0 11 13 2 0 0 0 0 11 23 1 0 0 0 0 12 14 2 0 0 0 0 12 24 1 0 0 0 0 13 14 1 0 0 0 0 13 25 1 0 0 0 0 15 16 1 0 0 0 0 15 17 1 0 0 0 0 15 18 1 0 0 0 0 16 26 1 0 0 0 0 16 27 1 0 0 0 0 16 28 1 0 0 0 0 17 29 1 0 0 0 0 17 30 1 0 0 0 0 17 31 1 0 0 0 0

4. International Nomenclature & Identifiers

4.1 IUPAC Name

2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid

4.2 InChI

InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)

1. Primary Information

2. Suppliers & Pricing

3. Structures

3.1 2D structure

3.2 3D structure

4. International Nomenclature & Identifiers

4.1 IUPAC Name

4.2 InChI

4.3 InChIKey

4.4 Canonical SMILES

4.5 Isomeric SMILES

4.6 SDF file

5. Spectroscopic data

5.1 ¹³C nuclear magnetic resonance (¹³C NMR)

5.2 ¹H nuclear magnetic resonance (¹H NMR)

5.3 Mass spectrometry (MS)

5.4 Infrared spectroscopy (IR)

5.5 Ultraviolet/visible spectroscopy (UV/Vis)

1. Primary Information

2. Suppliers & Pricing

3. Structures

3.1 2D structure

3.2 3D structure

4. International Nomenclature & Identifiers

4.1 IUPAC Name

4.2 InChI

4.3 InChIKey

4.4 Canonical SMILES

4.5 Isomeric SMILES

4.6 SDF file

5. Spectroscopic data

5.1 13C nuclear magnetic resonance (13C NMR)

5.2 1H nuclear magnetic resonance (1H NMR)

5.3 Mass spectrometry (MS)

5.4 Infrared spectroscopy (IR)

5.5 Ultraviolet/visible spectroscopy (UV/Vis)

5.1 ¹³C nuclear magnetic resonance (¹³C NMR)

5.2 ¹H nuclear magnetic resonance (¹H NMR)